Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

Good post inside. Unfortunately, the company has destroyed investor confidence in management and the stock. The Crede deal was unimaginable pricing the company at 2.11. Couple that with poor sales and shorts not covering at this price. I'm starting to think more bad news is coming (with or without European Approval) and the company (and the shorts) are already well aware of it.

I believe the stock IS significantly undervalued at 1.45. The company is not helping market perception right now, and no one seems to know what will help. You mention several good possible catalysts, but the imminent danger of another financing deal may destroy the company once and for all. It seems to me as if this is the destiny to come.

If European Approval of Lymphioseek is granted and is for the expanded label, THAT in my opinion could really turn things around as the FDA should conceivably follow in granting the extended applications with the anticipated sNDA.

The way the stock is presently trading though, share price and shareholder value seem to be the company's lowest priority by far.